Dear Congress, the PTAB Hinders Innovation and Threatens National Security

The Patent Trial and Appeal Board (PTAB) effectively invalidates 84% of the patents it fully adjudicates. That fact comes directly from the U.S. Patent and Trademark Office’s (USPTO) PTAB Trial Statistics FY23 End of Year Outcome. This astronomical PTAB invalidation rate has effectively shut down investment in early-stage startups, particularly in vital sectors that require […]

China Uses the USPTO to Take a Critical Minerals Market

The Chinese Communist Party (CCP) has perfected the art of stealing U.S. technologies and taking control of entire markets. Their methods range from the well-known, like forced technology transfers or outright stealing technology, to more subtle methods like enlisting the U.S. government to destroy U.S. company patents, clearing the way for the CCP to dominate […]

U.S. Innovation was on the Table in the Senate Hearing on PERA

On Tuesday, January 23, 2024, the Senate Judiciary’s IP Subcommittee held a hearing on the Patent Eligibility Restoration Act (PERA). The corporate lobbyists tell us that PERA will fix patent eligibility problems plaguing U.S. innovation for biotech, diagnostic methods, and inventions implemented in software.   In his opening statement, Senator Tillis said, “We’ve said many […]